Form D · Biotechnology
Celularity Inc
Florham Park, NJ · CIK 0001752828
Offering snapshot reported Nov 3, 2025 · SEC filing
- Reported sold
- $2M Offering amount: $6.67M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 24, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 3, 2025 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Aug 5, 2025 | Initial | $6,812,230 | No comparison | 1 | SEC filing |
| Aug 5, 2025 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Aug 5, 2025 | Initial | $1,035,000 | No comparison | 14 | SEC filing |
| May 27, 2022 | Initial | $30,000,007 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562871
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Nov 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David C. Beers | Executive |
| Jay R. Bloom | Director |
| Stephen A. Brigido | Executive |
| Peter Diamandis | Director |
| Joseph Dos Santos | Executive |
| Keary Dunn | Executive |
| Bradley Glover | Executive |
| John R. Haines | Executive |
| Robert J. Hariri | Director, Executive |
| Anne Jones | Executive |
| Dean C. Kehler | Director |
| Vincent Le Vien | Director |
| Geoffrey Ling | Director |
| Marc Mazur | Director |
| Diane Parks | Director |
| Andrew L. Pecora | Executive |
| John Sculley | Director |
| Robin L. Smith | Director |
| Lim Kok Thay | Director |
| Andrew C. Von Eschenbach | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
170 Park Avenue
Florham Park, NJ, 07932
Florham Park, NJ, 07932